Bayer reaches $2 billion deal over future Roundup claims
Story Date: 2/4/2021

 

Source: Tom Hals and Tina Bellon, ST. LOUIS DISPATCH, 2/4/21

 
Bayer AG struck a $2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer, the German company said Wednesday. Bayer has been struggling to finalize the settlement of claims that Roundup and other glyphosate-based herbicides cause non-Hodgkin’s lymphoma, a type of cancer. Bayer inherited the business and the litigation as part of its $63 billion acquisition of Creve Coeur-based Monsanto in 2018.

For more of this story, click here. 


























   Copyright © 2007 North Carolina Agribusiness Council, Inc. All Rights Reserved.
   All use of this Website is subject to our
Terms of Use Agreement and our Privacy Policy.